Canadian Institutes of Health Research
Français Contact UsHelpSearchCanada Site
CIHR HomeAbout CIHRWhat's NewFunding OpportunitiesFunding Decisions
CIHR | IRSC
CIHR Institutes
ICR Home
About ICR
Research Priorities
Scientific Director
Advisory Board
Facts & Figures
ICR Funding
ICR Publications & Resources
Contact ICR
 
ICR > About ICR > Scientific Director

Institute of Cancer Research (ICR)

Message from Dr. Philip Branton, Scientific Director - Institute of Cancer Research

It is a great honour to be named Director of the CIHR Institute of Cancer Research. The opportunities to strengthen and expand health research through the formation of CIHR are truly exciting. Cancer in particular should benefit, as we now have the possibility to enhance ongoing cancer research, to create new cancer research programs, and to co-ordinate Canada-wide cancer research efforts supported by different national and provincial agencies. These efforts are even more critical as we are entering a new era in the way we diagnose and treat cancer.

The next five to ten years will unquestionably see a revolution that will greatly reduce or eliminate the severe effects of many forms of cancer. Dramatic advances in genomics and functional proteomics will allow much more effective cancer diagnosis, prevention and therapeutic intervention. The Institute of Cancer Research must be well positioned to support and facilitate the onset of this new age as our successes will create a great number of exciting new research challenges in population health and health delivery, as well as in critical basic and clinical research issues. I greatly look forward to working with many of you to create an exciting and world-class environment for cancer research.

Modified: 2003-05-08
Reviewed: 2003-05-08
Print